GRT-R904
Showing 1 - 25 of 736
Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)
Recruiting
- Non-Small Cell Lung Cancer
- +4 more
- GRT-C903
- +3 more
-
Phoenix, Arizona
- +13 more
Jan 30, 2023
COVID-19, SARS-CoV-2 Trial in Johannesburg, Pretoria (GRT-R912, samRNA-Spikebeta-TCE11, GRT-R914, samRNA-Spikebeta-TCE9,
Recruiting
- COVID-19
- SARS-CoV-2
- GRT-R912, samRNA-Spikebeta-TCE11
- +2 more
-
Johannesburg, South Africa
- +1 more
Jun 24, 2022
COVID-19 Trial in Birmingham, Leicester, Manchester (GRT-R910 10 mcg Dose (after AZ), GRT-R910 30 mcg Dose (after AZ), GRT-R910
Recruiting
- COVID-19
- GRT-R910 10 mcg Dose (after AZ)
- +3 more
-
Birmingham, United Kingdom
- +2 more
Aug 15, 2022
Colonic Tumors, Colorectal Tumors Trial in Detroit, New York, Cincinnati (GRT-C901, GRT-R902, Atezolizumab)
Recruiting
- Colonic Neoplasms
- Colorectal Neoplasms
- GRT-C901
- +4 more
-
Detroit, Michigan
- +2 more
Aug 1, 2022
Non Small Cell Lung Cancer, Colorectal Cancer, Gastroesophageal Adenocarcinoma Trial in Australia, United States (GRT-C901,
Active, not recruiting
- Non Small Cell Lung Cancer
- +3 more
- GRT-C901
- +3 more
-
Phoenix, Arizona
- +10 more
Aug 31, 2021
HIV-1-infection Trial in Lesotho, Tanzania (Clinical management informed by HIV-1 genotypic resistance testing)
Active, not recruiting
- HIV-1-infection
- Clinical management informed by HIV-1 genotypic resistance testing
-
Seboche, Butha-Buthe, Lesotho
- +9 more
Dec 4, 2022
Malignant Glioma, Recurrent Glioma Trial in Beijing (personalized vaccine)
Recruiting
- Malignant Glioma
- Recurrent Glioma
- personalized vaccine
-
Beijing, Beijing, ChinaXuanwu Hospital, Capital Medical University
Jun 26, 2021
Ulcerative Colitis Trial in Worldwide (Placebo, Guselkumab)
Active, not recruiting
- Ulcerative Colitis
- Placebo
- Guselkumab
-
Lancaster, California
- +390 more
Jan 17, 2023
Advanced Malignant Solid Tumor, Anal Carcinoma, HIV Infection Trial in Australia, United States (Ipilimumab, Nivolumab)
Recruiting
- Advanced Malignant Solid Neoplasm
- +8 more
- Ipilimumab
- Nivolumab
-
La Jolla, California
- +34 more
Nov 29, 2022
Spondyloarthritis Trial in Worldwide (Upadacitinib, Placebo)
Active, not recruiting
- Spondyloarthritis
- Upadacitinib
- Placebo
-
Flagstaff, Arizona
- +211 more
Oct 19, 2021
HIV/AIDS Trial in Phnom Penh (Dolutegravir + Darunavir/ritonavir + optimized NRTI)
Recruiting
- HIV/AIDS
- Dolutegravir + Darunavir/ritonavir + optimized NRTI
-
Phnom Penh, CambodiaNCHADS
Aug 25, 2021
Pharmacokinetic Trial in Miami, Orlando (Cebranopadol 200 µg tablet)
Completed
- Pharmacokinetic
- Cebranopadol 200 μg tablet
-
Miami, Florida
- +1 more
Jul 13, 2021
Breast Cancer Trial in Worldwide (Olaparib, Placebo)
Transcatheter TRIcuspid Valve RePLACEment
Not yet recruiting
- Tricuspid Regurgitation
- Transcatheter Tricuspid Valve Replacement
-
Bronx, New York
- +3 more
Sep 5, 2023
Coronary Artery Disease Trial in Jacksonville (aspirin plus clopidogrel, prasugrel or ticagrelor)
Not yet recruiting
- Coronary Artery Disease
- aspirin plus clopidogrel
- prasugrel or ticagrelor
-
Jacksonville, FloridaUniversity of Florida
Jan 4, 2023